ARIAD to Present at the Morgan Stanley Global Healthcare Conference
August 29 2016 - 7:35AM
Business Wire
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that
it will present at the Morgan Stanley Global Healthcare Conference
being held in New York City. Paris Panayiotopoulos, president and
chief executive officer, will provide an overview of the Company’s
business on Monday, September 12, 2016 at 2:50 p.m. (ET).
The ARIAD presentation will be webcast live and can be accessed
by visiting the investor relations section of the Company's website
at http://www.ariad.com/investor. A replay of the presentation will
also be available and archived on the site for three weeks.
About ARIAD
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge,
Massachusetts is focused on discovering, developing and
commercializing precision therapies for patients with rare cancers.
ARIAD is working on new medicines to advance the treatment of rare
forms of chronic and acute leukemia, lung cancer and other rare
cancers. ARIAD utilizes computational and structural approaches to
design small-molecule drugs that overcome resistance to existing
cancer medicines. For additional information, visit
http://www.ariad.com or follow ARIAD on Twitter (@ARIADPharm).
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160829005095/en/
ARIAD PharmaceuticalsFor InvestorsManmeet Soni,
617-503-7298Manmeet.soni@ariad.comorFor MediaLiza Heapes,
617-621-2315Liza.heapes@ariad.com
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From May 2024 to Jun 2024
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Jun 2023 to Jun 2024